Table 2.

Correlation of clinicopathologic characteristics with CD163 and MARCO expression.

Characteristics	CD163			MARCO
	High	Low	P-value	High	Low		P-value
Age(years)
≤60	13	20		20		13
>60	11	21	0.675	13		19	0.107
Gender
Male	18	25		19		14
Female	6	16	0.249	14		18	0.265
ECOG PS
=0	15	38		22		31
=1	9	3	0.002	11		1	0.002
Site of primary tumor
Head	8	6		7		7
Body and tail	16	35	0.077	26		25	0.948
Size of primary tumor(cm)
≥5	9	8		10		7
<5	15	33	0.111	23		25	0.440
Histopathological grading
High	7	2		1		8
Intermediate and low	17	39	0.006	32		24	0.010
TNM stage
I and II	14	39		22		31
III	10	2	0.000	11		1	0.002
CA19-9 (U/mL)
<37	10	18		12		16
≥37	14	23	0.861	21		16	0.267
CEA (ng/mL)
<3.5	11	19		13		17
≥3.5	13	22	0.968	20		15	0.267
ALT(U/L)
<75	20	35		27		28
≥75	4	6	0.827	6		4	0.526
AST (U/L)
<75	19	34		28		25
≥75	5	7	0.706	5		7	0.485
Total bilirubin
<75	17	32		27		22
≥75	7	9	0.515	6		10	0.221
Direct bilirubin
<75	18	31		25		24
≥75	6	10	0.956	8		8	0.943
Indirect bilirubin
<75	18	30		24		24
≥75	6	11	0.871	9		8	0.835
WBC
<3.5x109	5	9		6		8
≥3.5x 109	19	32	0.916	27		24	0.504
RBC
<3.5x1012	4	6		5		5
≥3.5x 1012	20	35	0.827	28		27	0.958
HGB(g/dL)
<15	5	8		7		6
≥15	19	33	0.898	26		26	0.804
PLT
<100x109	7	10		9		8
≥100x 109	17	31	0.672	24		24	0.835